These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3155635)

  • 1. Fatal multisystemic toxicity associated with prophylaxis with pyrimethamine and sulfadoxine (Fansidar).
    Selby CD; Ladusans EJ; Smith PG
    Br Med J (Clin Res Ed); 1985 Jan; 290(6462):113-4. PubMed ID: 3155635
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal hepatic necrosis due to pyrimethamine-sulfadoxine (Fansidar).
    Zitelli BJ; Alexander J; Taylor S; Miller KD; Howrie DL; Kuritsky JN; Perez TH; Van Thiel DH
    Ann Intern Med; 1987 Mar; 106(3):393-5. PubMed ID: 2949680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse reactions to Fansidar.
    Kollisch DO
    J Fam Pract; 1986 Sep; 23(3):202-4. PubMed ID: 2943869
    [No Abstract]   [Full Text] [Related]  

  • 4. Unusual pulmonary reaction during short term prophylaxis with pyrimethamine-sulfadoxine (Fansidar).
    Svanbom M; Rombo L; Gustafsson L
    Br Med J (Clin Res Ed); 1984 Jun; 288(6434):1876. PubMed ID: 6428585
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute hepatitis following administration of fansidar].
    Meier P; Schmid M; Stäubli M
    Schweiz Med Wochenschr; 1990 Feb; 120(7):221-5. PubMed ID: 2309111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fansidar for malaria prophylaxis.
    Kissane D
    Aust Fam Physician; 1985 Aug; 14(8):738. PubMed ID: 3901990
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis.
    Hellgren U; Rombo L; Berg B; Carlson J; Wiholm BE
    Br Med J (Clin Res Ed); 1987 Aug; 295(6594):365-6. PubMed ID: 2958104
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulfadoxine specific lymphocyte transformation in a patient with eosinophilic pneumonia induced by sulfadoxine-pyrimethamine (Fansidar).
    Daniel PT; Holzschuh J; Berg PA
    Thorax; 1989 Apr; 44(4):307-9. PubMed ID: 2763233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The reliability and side effects of malaria chemoprophylaxis].
    Steffen R; Heusser R
    Schweiz Rundsch Med Prax; 1986 Apr; 75(16):446-8. PubMed ID: 2939527
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver damage associated with fansidar.
    Wejstal R; Lindberg J; Malmvall BE; Norkrans G
    Lancet; 1986 Apr; 1(8485):854-5. PubMed ID: 2870335
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis.
    Miller KD; Lobel HO; Satriale RF; Kuritsky JN; Stern R; Campbell CC
    Am J Trop Med Hyg; 1986 May; 35(3):451-8. PubMed ID: 2939735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is the use of Fansidar as an antimalarial justified?].
    Olsen VV
    Ugeskr Laeger; 1985 Feb; 147(7):624-5. PubMed ID: 3976083
    [No Abstract]   [Full Text] [Related]  

  • 13. [Eosinophilic lung infiltration during malaria prophylaxis with pyrimethamine-sulfadoxine (Fansidar)].
    Buser P; Räber J
    Schweiz Med Wochenschr; 1985 Aug; 115(34):1174-6. PubMed ID: 4048913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fansidar and hepatic granulomas.
    Lazar HP; Murphy RL; Phair JP
    Ann Intern Med; 1985 May; 102(5):722. PubMed ID: 3985527
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jan; 33(51-52):713-4. PubMed ID: 3917533
    [No Abstract]   [Full Text] [Related]  

  • 16. Does chloroquine contribute to the risk of serious adverse reactions to fansidar?
    Rombo L; Stenbeck J; Lobel HO; Campbell CC; Papaioanou M; Miller KD
    Lancet; 1985 Dec; 2(8467):1298-9. PubMed ID: 2866354
    [No Abstract]   [Full Text] [Related]  

  • 17. Leads from the MMWR. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria.
    JAMA; 1985 Jan; 253(4):483. PubMed ID: 3881605
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatal Stevens-Johnson syndrome associated with Fansidar and chloroquine.
    Bamber MG; Elder AT; Gray JA; Minns RA
    J Infect; 1986 Jul; 13(1):31-3. PubMed ID: 3734464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serious reactions during malaria prophylaxis with pyrimethamine-sulfadoxine.
    Olsen VV; Loft S; Christensen KD
    Lancet; 1982 Oct; 2(8305):994. PubMed ID: 6127497
    [No Abstract]   [Full Text] [Related]  

  • 20. Boxed warning added to Fansidar labeling.
    FDA Drug Bull; 1985 Aug; 15(2):21. PubMed ID: 4054454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.